Evidence map›Paper›PMID 38074044›Full record

ReviewCureus2023

Efficacy and Safety of Potassium-Competitive Acid Blockers Versus Proton Pump Inhibitors as Helicobacter pylori Eradication Therapy: A Meta-Analysis of Randomized Clinical Trials.

Abdullah Shah, Omer Usman, Tafseer Zahra, Sandipkumar S Chaudhari, Gopi Sairam Reddy Mulaka, Rumaisa Masood, Saima Batool, Faraz Saleem

Registry-linked trialOpen access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06318104 (Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Amoxicillin 1g + Clarithromycin 500 mg and Tegoprazan 50 mg vs Amoxicillin 1g + Clarithromycin 500 mg and Esomeprazole 40 mg Twice a Day for 14 Days), which is not on this map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06318104 phase4unknown statusnot on this mapstarted 2024, after this paper: background citation

Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Amoxicillin 1g + Clarithromycin 500 mg and Tegoprazan 50 mg vs Amoxicillin 1g + Clarithromycin 500 mg and Esomeprazole 40 mg Twice a Day for 14 Days

TypeinterventionalSponsorHospital General de México Dr. Eduardo LiceagaRan2024 to 2025Enrolled160ConditionsHelicobacter Pylori InfectionArmsTegoprazan, Esomeprazole 40mg
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. [Treatment status and progress of laryngopharyngeal reflux disease].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 4 countries.

Abdullah ShahNephrology, Rehman Medical Institute, Peshawar, PAK.
Omer UsmanInternal Medicine, Texas Tech University Health Sciences Center El Paso, Houston, USA.
Tafseer ZahraMedicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Sandipkumar S ChaudhariCardiothoracic Surgery, University of Alabama at Birmingham, Birmingham, USA.
Gopi Sairam Reddy MulakaInternal Medicine/Human Physiology, St. Martinus University Faculty of Medicine, Willemstad, CUW.
Rumaisa MasoodInternal Medicine, Services Institute of Medical Sciences, Lahore, PAK.
Saima BatoolInternal Medicine, Hameed Latif Hospital, Lahore, PAK.
Faraz SaleemInternal Medicine, Akhtar Saeed Medical & Dental College, Lahore, PAK.
Farooq Hospital · PKLatifa Hospital · AECMH Lahore Medical College and Institute of Dentistry · PKHayatabad Medical Complex · PKSt. Martinus University · CWTexas Tech University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

eradicationhelicobacter pylorimeta-analysispotassium-competitive acid blockersproton pump inhibitorsrandomized clinical trialssystematic review

Identifiers

PMID38074044
PMCPMC10703517
OpenAlexW4388448255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.